Cerecor Inc.
Cerecor Inc. (CERC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CERC · as of Jun 9, 2026
Key Statistics
Explore Cerecor Inc. Data
cerc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 83.3%
Competitors & Peers
cerc competitorsCERC
GRCE
IRD
LIANY
LUMO
MGTAStock Performance
Full HistoryAbout Cerecor Inc.
Cerecor Inc. operates as a biopharmaceutical firm dedicated to the discovery and marketing of therapeutic solutions, primarily addressing rare pediatric and orphan diseases. The company maintains an a…
what is cerecor inc. · cerc stock overview · cerecor inc. company profile · who is cerecor inc. ceo · cerc NASDAQ · cerecor inc. headquarters · cerecor inc. business segments
About Stock Overview & Key Data
Cerecor Inc. (CERC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 13, 2015. As of the latest trading session, CERC stock price is $2.93, with a market capitalization of $38.6M. The stock has returned -71.71% over the past 12 months and +0.00% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Cerecor Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Cerecor Inc. reported revenue of $59000.00 and net income of -$78.3M. For detailed data — including Cerecor Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cerecor Inc. (CERC) stock price is $2.93. The stock is traded on NASDAQ under the ticker symbol CERC. The 52-week range is $2.90 – $2.98.